To carry out a metaanalysis of antidepressant studies to calculate the effect sizes for antidepressant effect in depressive disorder.
Method:
A metaanalysis of all antidepressant studies that included an active comparison drug as well as placebo was used to calculate the effect size. Articles were selected from a MEDLINE search for the period January 1966 to June 1995. Forty-nine studies were included in the metaanalysis.
Results:
The effect sizes for antidepressant treatment are moderately larger than for placebo. A larger effect size was observed in studies where objective diagnostic criteria for depression were used.
Conclusions:
We conclude that the superior efficacy of antidepressants over placebo can be demonstrated.
AndersonIMTomensonBM. The efficacy of selective serotonin re-uptake inhibitors in depression: A meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol1994;8:238–42.
2.
KasperSFugerJMollerHJ. Comparative efficacy of antidepressants. Drugs1992;43:11–23.
3.
SongSFreemantleNSheldonTAHouseAWatsonPLongA, and others. Selective serotonin re-uptake inhibitors: Meta-analysis of efficacy and acceptability. BMJ1993;306:683–7.
4.
GreenbergRPBornsteinRFGreenbergMDFisherS.A meta-analysis of antidepressant outcome under “blinder” conditions. J Consult Clin Psychol1992; 60:664–9.
5.
HedgesLVOlkinI.Statistical methods for meta-analysis. Orlando: Academic Press; 1995.
6.
AmsterdamJDCaseWGCsanalosiESingerMRickelsK.A double-blind comparative trial of zimelidine, amitriptyline and placebo in patients with mixed anxiety and depression. Pharmacopsychiatry1986;19:115–9.
7.
BakishDWiensAEllisJAldaMLapierreY.A double-blind, placebo-control comparison of moclobemide and amitriptyline in the treatment of depression. Can J Psychiatry1992;37(1 Suppl):12S–17S.
8.
CassanoGBContiLMassimettiGMengaliFWaekelinJSLevineJ.Use of a standardized documentation system (BLIPS/BDP) in the conduct of a multicentre international trial comparing fluvoxamine, imipramine and placebo. Psychopharmacol Bull1986;22:52–8.
9.
ChouinardGSaxenaBMNairNPVKutcherSPBakishDBradwejnJ, and others. A Canadian multicentre placebo-control study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression. J Affect Disord1994;32:105–14.
10.
ClaghornJGershonSGoldsteinBJBehmetzSBushDFHuitfeldtB.A double-blind evaluation of zimelidine in comparison to placebo and amitriptyline in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry1983;7:367–92.
11.
CohnJBWilcoxC.A comparison of fluvoxamine, imipramine and placebo in patients with major depressive disorder. J Clin Psychiatry1985;46:26–31.
12.
CunninghamLABorisonRLCarmanJSChouinardGCrowderJEDiamondBI, and others. A comparison of venlafaxine, trazodone, and placebo in major depression. J Clin Psychopharmacol1994;14:99–106.
13.
DominguezRJacobsonAFWeissBLGoldsteinBJSteinbookRM. A placebo-control comparison of amoxapine and imipramine in the treatment of depressed outpatients. Current Therapeutic Research1981;29:714–27.
14.
DominguezRAGoldsteinBJJacobsonAFSteinbookRM. A double-blind placebo-control study of fluvoxamine and imipramine in depression. J Clin Psychiatry1985;46:84–7.
15.
DooganDPLangdonCJ. A double-blind, placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice. Int Clin Psychopharmacol1994;9:95–100.
16.
DunbarGCCohnJBFabreLFFeighnerJPFieveRRMendelsJ, and others. A comparison of paroxetine, imipramine and placebo in depressed outpatients. Br J Psychiatry1991;159:394–8.
17.
EscobarJIGomezJConstainCReyJSantacruzH.Controlled clinical trial with trazodone, a novel antidepressant: A self American experience. J Clin Pharmacol1980;20:124–30.
18.
FabreLFMcLendonDMGaineyA.Trazodone efficacy in depression: A double-blind comparison with imipramine and placebo in day hospital type patients. Current Therapeutic Research1979;25:826–34.
19.
FeighnerJP. Trazodone, a triazolopyridine derivative, in primary depressive disorder. J Clin Psychiatry1980;41:250–5.
20.
FeighnerJPAdenGCFabreLFRickelsKSmithWT. Comparison of alprazolam, imipramine and placebo in the treatment of depression. JAMA1983;249:3057–64.
21.
FeighnerJPBoyerWFMeredithCHHendricksonGG. A double-blind comparison of fluvoxamine, imipramine and placebo in outpatients with major depression. Int Clin Psychopharmacol1989;94:127–34.
22.
FeighnerJPBoyerWFMeredithCHHendricksonGG. A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression. Int Clin Psychopharmacol1989;4:239–44.
23.
FeighnerJBPambakainRFowlerRCBoyerWFD'AmicoMF. A comparison of nefazodone, imipramine, and placebo in patients of moderate to severe depression. Psychopharmacol Bull1989;25:219–21.
24.
FergusonJMMendelsJManowitzNR. Dothiepin versus doxepin in major depression: Results of a multicentre, placebo-control trial. J Clin Psychiatry1994;55:258–63.
25.
FontaineROntivrosAElieR.A double-blind comparison of nefazodone, imipramine and placebo in major depression. J Clin Psychiatry1994;55:234–41.
26.
GelenbergAJWojcikJDFalkWESpringBBrokmanAWGlavin-NadeauM.Clovoxamine in the treatment of depressed outpatients: A double-blind parallel-group comparison against amitriptyline and placebo. Compr Psychiatry1990; 31:307–14.
27.
GershonSMMannJJNewtonRGuntherBJ. Evaluation of trazodone in the treatment of endogenous depression: Results of a multicentre double-blind study. J Clin Psychopharmacol1981;(1 Suppl):39S–44S.
28.
HicksFRobinsEMurphyGE. Comparison of adinazolam, amitriptyline and placebo in the treatment of melancholic depression. Psychiatry Res1988; 23:221–7.
29.
HormazabalLOmerLMOIsmailS.Cyanopramine and amitriptyline in the treatment of depressed patients—a placebo-control study. Psychopharmacology1985;86:205–8.
30.
LapierreYDBrowneMHornEOyewumiLKSarantidisDRobertsN, and others. Treatment of major affective disorder with fluvoxamine. J Clin Psychiatry1987;48:65–8.
31.
LarsenJKHolmPHoyerEMejlhedeAMikkelsenFLOlesenA, and others. Moclobomide and clomipramine in reactive depression: A placebo-controlled randomized trial. Acta Psychiatr Scand1989;79:530–6.
32.
LydiardRBLairdLKMortonWASteeleTEKellnerCLaraiaMT, and others. Fluvoxamine, imipramine and placebo in the treatment of depressed outpatients: Effects on depression. Psychopharmacol Bull1989;25:68–71.
33.
MannJJGeorgotasANewtonRGershonS.A controlled study of trazodone, imipramine and placebo in outpatients with endogenous depression. J Clin Psychopharmacol1981;1:75–80.
34.
MarchJSKobakKAJeffersonJWMazzaJGreistJH. A double-blind, placebo-control trial of fluvoxamine versus imipramine in outpatients with major depression. J Clin Psychiatry1990;51:200–2.
35.
MeridethCHFeighnerJP. A double-blind controlled evaluation of zimeldine, imipramine and placebo in patients with primary affective disorders. Acta Psychiatr Scand1983;68(308 Suppl):70S–79S.
36.
MuijenMRoyBSilverstoneTMehmetAChristieM.A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients. Acta Psychiatr Scand1988;78:384–90.
37.
NortonKRWSirelingLIBhatAVRaoBPaykelES. A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients. J Affect Disord1984;7:297–308.
38.
PaykelESRowanPRParkerRRBhatAV. Response to phenelzine, amitriptyline in subtypes of outpatient depression. Arch Gen Psychiatry1982;39:1041–9.
39.
RickelsSKCaseWGWerbolwskyJACsanalosiISchlessAWeiseCC. Amoxapine and imipramine in the treatment of depressed outpatients: A controlled study. Am J Psychiatry1981;138:20–4.
40.
RickelsKWeiseCCZalHMCsanalosiIWerblowskyJ.Lofepramine and imipramine in unipolar depressed outpatients. Acta Psychiatr Scand1982;66:104–20.
41.
RickelsKFeighnerJPSmithWT. Alprazolam, amitriptyline, doxepin and placebo in the treatment of depression. Arch Gen Psychiatry1985;42:134–41.
42.
RickelsKChungHRCsanalosiIBHurowitzAMLondonJWisemanK, and others. Alprazolam, diazepam, imipramine and placebo in outpatients with major depression. Arch Gen Psychiatry1987;44:862–6.
43.
RickelsKLondonJFoxIHassmanHCsanalosiIWeiseC.Adinazolam, diazepam, imipramine and placebo in major depressive disorder: A controlled study. Pharmacopsychiatry1991;24:127–31.
44.
RickelsKSchweizerEClaryCFoxIWeiseC.Nefazodone and imipramine in major depression: A placebo-control trial. Br J Psychiatry1994;154:802–5.
45.
SpringBGelenbergAJGarvinRThompsonS.Amitriptyline, clovoxamine and cognitive function. A placebo-control comparison in depressed outpatients. Psychopharmacology1992;108:327–32.
46.
ShrivastavaRKShrivastavaSHPOverwegNBlumhartCL. A double-blind comparison of paroxetine, imipramine and placebo in major depression. J Clin Psychiatry1992:53(2 Suppl):48S–51S.
47.
SmithWTGlaudinVPanagidesJGilvaryE.Mirtazapine versus amitriptyline versus placebo in the treatment of major depressive disorder. Psychopharmacol Bull1990;26:191–6.
48.
ThompsonJRankinHAshcorftWYatesCMMcQueenJKCummingsSW. The treatment of depression in general practice: A comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan in amitriptyline with placebo. Psychol Med1982;12:741–51.
49.
TrappGAHandorfCRLarachV.Trazodone in the treatment of depressed inpatients. Psychopharmacol Bull1979;15:25–7.
50.
UdabeRUMarquezGATraballiCAPortesN.Double-blind comparison of moclobemide, imipramine and placebo in depressed patients. Acta Psychiatr Scand1990;360:54–6.
51.
UK Moclobemide Study Group. A multi-centre comparative trial of moclobemide, imipramine and placebo in major depressive disorder. Int Clin Psychopharmacol1994;9:109–13.
52.
VersianiMOggeroUAlterwainPCapponiRDajasFHeinze-MartinG, and others. A double-blind comparative trial of moclobemide versus imipramine and placebo in major depressive episodes. Br J Psychiatry1989;155 (6 Suppl):72S–77S.
53.
VersianiMNardiAEMundimFDAlvesAB. Moclobemide, imipramine and placebo in the treatment of major depression. Acta Psychiatr Scand1990; 360:57–8.
54.
WilcoxCSCohnJBKatzBB. A double-blind, placebo-controlled study comparing mianserin and amitriptyline in moderately depressed outpatients. Int Clin Psychopharmacol1994;9:271–9.
